- Companies Plan to Submit Biologics License Application Later This Year -

- Investigational compound fezolinetant reduced frequency and severity of vasomotor symptoms in postmenopausal women -

Joint Project Will Explore Enhancements to Patient Communication and Shared Decision-Making

Data to be presented at the 2019 Genitourinary Cancers Symposium

Acquisition adds clinical stage novel immuno-oncology programs to Astellas' oncology pipeline